Combined Therapy Using Human Corneal Stromal Stem Cells and Quiescent Keratocytes to Prevent Corneal Scarring after Injury

Corneal blindness due to scarring is conventionally treated by corneal transplantation, but the shortage of donor materials has been a major issue affecting the global success of treatment. Pre-clinical and clinical studies have shown that cell-based therapies using either corneal stromal stem cells...

Descripción completa

Detalles Bibliográficos
Autores principales: Jhanji, Vishal, Santra, Mithun, Riau, Andri K., Geary, Moira L., Yang, Tianbing, Rubin, Elizabeth, Yusoff, Nur Zahirah Binte M., Dhaliwal, Deepinder K., Mehta, Jodhbir S., Yam, Gary Hin-Fai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9267074/
https://www.ncbi.nlm.nih.gov/pubmed/35805991
http://dx.doi.org/10.3390/ijms23136980

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9267074/
https://www.ncbi.nlm.nih.gov/pubmed/35805991
http://dx.doi.org/10.3390/ijms23136980

Ejemplares similares